Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Prion protein with gain of function found

Dec. 4, 2019

Japanese researchers patent TRPC3 and TRPC6 antagonists

Nov. 18, 2019

Aged gut microbiota transplants show benefits in young mice

Nov. 15, 2019

Medshine Discovery patents Rho kinase inhibitors

Nov. 11, 2019

PARP degradation joins trapping, inhibition

Nov. 6, 2019

Dopamine goes from pleasure to repair molecule

Nov. 5, 2019

Rightsizing brain activity increases lifespan, but REST is not all good

Oct. 31, 2019

Blade Therapeutics identifies new calpain inhibitors

Oct. 23, 2019

Mitochondrial mutations hamper nuclear DNA repair

Oct. 14, 2019

Potent new small-molecule inhibitors block apoptosis in mice

Oct. 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.